36C24524Q0625 Sources Sought Notice.docx

DOCX document 25 KB Posted

Attached to
Sources Sought for Radiopharmaceuticals
Solicitation number
36C24524Q0625
Issued by

About this file

This document is a Sources Sought Notice for radiopharmaceuticals to be provided to the Veterans Affairs Medical Centers (VAMCs) in DC, MD, and WV. The Network Contracting Office 5 is conducting this market research to identify contractors with the capability to deliver radiopharmaceuticals on a daily basis, including emergency orders. The required radiopharmaceuticals and delivery schedule are detailed in the Statement of Work. Interested parties are requested to submit their business information, capability statement, GSA contract details, and a summary of professional services by June 24, 2024. This Sources Sought Notice is for informational and planning purposes only and does not constitute a solicitation. Any future solicitation will require separate responses from interested parties.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

SOURCES SOUGHT NOTICE 36C24524Q0625

The Network Contracting Office 5 is conducting this Sources Sought to identify contractors who possess capabilities to provide the services described in the Statement of Work below for Radiopharmaceuticals.

As permitted by the FAR Part 10, this is a market research tool being utilized for the informational and planning purposes. Your responses will assist the Government in the development of its acquisition strategy.

Response is strictly voluntary – it is not mandatory to submit a response to this notice to participate in formal RFQ process that may take place in the future. However, it should be noted that information gathered through this notice may significantly influence our acquisition strategy. All interested parties will be required to respond separately to any solicitation posted as a result of this sources sought notice.

Respondents will not be notified of the results of the evaluation. We appreciate your interest and thank you in advance for responding to the sources sought.

This service will be implemented using the North American Industry Classification System (NAICS) Code 325412.

NOTES

All Capability Statements/Responses to this Sources Sought Notice shall be submitted via email only to kenneth.dougherty@va.gov. Telephone, Fax, or any other form of communication inquiries will not be reviewed or accepted. Responses to this Sources Sought Notice must be received no later than June 24, 2024 at 3:00 p.m. (Eastern Standard Time). This Sources Sought Notice may or may not assist the VA in determining sources only. A solicitation is not currently available. If a solicitation is issued, it may or may not be announced at a later date, and all interested parties shall respond to that solicitation announcement separately from the responses to this Sources Sought Notice.

DISCLAIMER

This Sources Sought Notice is issued for information and planning purposes only and does not constitute a solicitation. All information received in response to this Sources Sought Notice that is marked a proprietary will be handled accordingly in accordance with (IAW) Federal Acquisition Regulation (FAR) 15.201(e), RFIs may be used when the Government does not presently intend to award a contract, but wants to obtain price, delivery, other market information, or capabilities for planning purposes. Responses to these notices are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses incurred associated with responding to this RFI.

INTERESTED & CAPABLE RESPONSES:

NCO 5 is seeking responses from businesses that are interested in this procurement and consider themselves to have the resources, rights, and capabilities necessary to provide these services. Please respond with your:

1. Business name (including Unique Entity ID (SAM.gov), business type, socio-economic status (e.g., Veteran-Owned, Woman-Owned, Disadvantaged Small Business, 8(a), etc.), person of contact (including telephone number & email address).

1. Capability statement

1. GSA Contract number, if applicable, to include NAICS

1. Brief summary of categories of professional services that your company can provide.

Applicable Certification(s)/Licenses

Statement of Work

RADIOPHARMACEUTICALS

DESCRIPTION

The Contractor shall provide and deliver radiopharmaceuticals to the Nuclear Medicine Section, Radiology Service at the Veterans Affairs Medical Center (VAMC) in DC, MD, and WV VAMCs. Deliveries shall be made, Monday thru Sunday on a scheduled time from a given list of radiopharmaceuticals. The Contractor shall be able and/or capable of providing emergency orders on demand during normal duty hours and after normal duty hours.

DELIVERY

The Contractor shall deliver the first shipment of daily radiopharmaceuticals orders needs to be delivered by 6:00am, second shipment by 10:00am and third shipment by 2:00pm.

All emergency orders for radiopharmaceutical doses will be placed by a nuclear medicine staff technologist on an emergency need basis. The contractor will deliver all emergency Radiopharmaceuticals doses within two hours of the dose being ordered to the Nuclear Medicine Department.

Due to the demands of the Medical Center care requirements, there shall be no restriction to the number of orders which may be placed by VA, nor the number of deliveries required per day Mon- Fri 630am - 430pm.

The Contractor shall supply a standing order of bulk LEU Technetium 99m in the amount of eighty (80) millicuries calibrated for 8 am and one hundred (100) millicuries calibrated for 4pm Mon-Fri and for Saturday and Sunday one hundred (100) millicuries with a calibration time of 8am and 4pm unless cancelled by the Contracting Officer’s Technical Representative (COTR) or designee.

The contractor shall provide capability for online/web ordering of all radiopharmaceuticals.

A daily packing slip should accompany all Radiopharmaceutical shipments to the Nuclear Medicine Department for all orders placed. The packing slip shall include a bar code that’s compatible and also be able to be scanned into the Nuclear Pharmacy Management System (NMIS) for tracking purposes. The delivery order shall specify contract item (s) and quantity, time (s) of delivery.

The contractor will calibrate all Radiopharmaceutical doses to ensure proper activity ranges of +/-10 percent of the specified ordered dose based on specific requirements provided by the Nuclear Medicine Department based on guidelines outlined in 10 CFR Part 35. The Contractor will ensure that all Radiopharmaceuticals doses provided are compound and calibrated by or under the supervision of a certified pharmacist.

The contractor shall provide any training or education required to meet commercial standards related to use of radiopharmaceuticals to all staff Nuclear Medicine Technologists stationed at VAMCs.

Description of Supplies

Item No.
Name
Manufacturer Part Number (MPN)
1
Tc-99m Sestamini UD, Dose 1-30 mCi
102994
2
Tc-99m Tetrofosmin UD, Does 1-30 mCi
103006
3
Tc-99m NaTcO4 MD, mCi
102983
4
Tc-99m NaTcO4 UD mCi, Dose 1.30 mCi
102984
5
Tc-99m Macro Aggregated Albumin UD *, Dose 1-7 mCi
102970
6
Tc-99m Mebrofenin UD, Dose 1-8 mCi
102974
7
Tc-99m Mebrofenin/Choletec, Dose 5 mCi
102974
8
Tc-99m Mertiatide UD *, Dose 1-10 mCi
102980
9
Tc-99m Oxidronate UD *, Dose 1.25 mCi
102986
10
Tc-99m MAA reduced particle, Dose 1-7 mCi
103728
11
Tc-99m sulfur colloid egg substitute, Dose 1 mCi
108001
12
Tc-99m sulfur colloid egg, Dose 1 mCi
108001
13
Tc-99m sulfur colloid UD, Dose 1 mCi
103003
14
Tc-99m Pyrophosphate UD, Dose 1-30 mCi
102991
15
Tc-99m Filtered Sulfur Colloid UD, Dose 2 mCi
102943
16
Tc-99m Pentetate (Aerosol) UD, Dose 40 mCi
102990
17
Tc-99m Lymphoseek UD, Dose 500 uCi
102967
18
Tc-99m MDP, Dose 25 mCi
102977
19
Tc-99m Ceretec Tagged WBC Scan, UD
103012
20
Tc-99m Cardiolite (sestamini) UD, Dose 20 mCi
102994
21
I-123 USP Nal 200 uCi Cap, CAP 200iCi
102338
22
I-123 lobenguane Sulfate UD, Dos 10 mCi
102330
23
I-131 USP Nal DX Cap mCi * (Base), Dose 1-6 mCi
102366
24
I-131 USP Nal DX Cap mCi (each additional mCi) * (mCi)
102366
25
I-131 USP Nal DX Cap uCi *
102367
26
I-131 USP Nal TX Cap * (Base) Dose 1-6 mCi
102372
27
I-131 USP Nal TX Cap (each additional mCi) * (mCi)
102372
28
In-111 Autologous WBC Suspension * 1-25 mCi
102410
29
Macro Aggregated Albumin Vial *
102659
30
Mebrofenin Vial
102574
31
Oxidronate Vial *
102635
32
Sincalide Vial *
102767
33
Sincalide Solution UD, Dose 1.55-2.1 ug
34
Penetetate Vial *
102653
35
I123 loflupane, Dose 10 mCi
108640
36
UltraTag Vial, Vial
103080
37
Tc-99m Tilmanocept, Dose up to 1 mCi
103931
38
F-18 FDG UD, Dose 1-15 mCi
102192
39
Ga68 Illuccix, Dose 1-5 mCi
108467
40
Ga68 Locametz, Dose 3-7 mCi
41
Ga68 NetSpot, Dose 5 mCi
105765
42
Cu64 DetectNet, Dose 4 mCi
107858
43
F-18 NaF UD, Dose 1015 mCi
102204
44
Ga-67 Gallium Citrate UD, Dose 4-8 mCi
102279
45
1-131 USP NAI TX Cap, Dose 10-200 mCi
102372
46
In-111 Pentetreotide UD, Dose 6 mCi
102400
47
In-111 WBC Blood Heparin, Kit
102409
48
TI-201 Thallous Chloride UD, Dose 1 & 3 mCi
103039
49
Ra-223 Dichloride (Xofigo), UD
102692
50
Tc-99m Pentetate (DTPA)
51
I-123 USP Nal 100 uCi Cap
52
Tc-99m Mertiatide (MAG3)
53
In-111 Autologous WBC Suspension
54
Tc-99m Pyrophosphate (Pyrolite)
55
Tc-99m Mebrofenin UD (choletec)
56
Tc-99m NaTcO4 UD mCi
57
Tc-99m Oxidronate UD (HDP)
58
Tc-99m Sestamibi UD (Cardiolite)
59
Tc-99m sulfur colloid UD
60
Tc-99m Tetrofosmin (Myoview)
61
Tc-99m Exametazime (HMPAO) - Ceretec
62
On-111-Octreoscan
63
10mCi Cobalt57 Sheet Source
64
PYP

File details come from the government source that posted it. Updated .